DaVita healthCare Partners Inc Stock News

Davita Inc (NYSE:DVA) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 6,040,000 shares, a growth of 5.6% from the June 30th total of 5,720,000 s

Stocks Analysis by Zacks Investment Research covering: S&P 500, Microsoft Corporation, DaVita HealthCare Partners Inc, Packaging Corp of America. Read Zacks Investment Research's latest article on Inv

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

DVA vs. CHE: Which Stock Is the Better Value Option?

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sumitomo Mitsui Trust Holdings Inc. trimmed its holdings in shares of Davita Inc (NYSE:DVA) by 26.1% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional

Davita (NYSE:DVA) and CRYO-CELL International (OTCMKTS:CCEL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional

Nisa Investment Advisors LLC grew its position in Davita Inc (NYSE:DVA) by 27.9% in the second quarter, HoldingsChannel reports. The fund owned 35,778 shares of the company’s stock after acquiring a

DaVita's (DVA) dialysis services in the United States were solid in Q2.

Get ready for a torrent of special-interest spending on California ballot measures.

DVA earnings call for the period ending June 30, 2020.

DaVita Inc. (NYSE:DVA) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Jim Gustafson - Vice President of Investor Relations Javier Rodriguez - Chief Executive Officer Jo

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 51.16% and -1.13%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

If you want to invest in stocks right now, it will be prudent to take a look at Warren Buffett's holdings. Warren Buffett has been one of the ...

TCR2 announced interesting preliminary results from a Phase 1 trial. The stock is up in pre-market trading.